Luglio 21, 2021 Claris Ventures announces final closing: €85m ($100m) for Italian Biotech Fund oversubscription, […] Claris Biotech I Final Closing
Marzo 9, 2021 NeoPhore Announces $21m Financing to Advance DNA Mismatch Repair Pipeline Round led […] NeoPhore Announces $21m Financing to Advance DNA Mismatch Repair Pipeline
Settembre 1, 2020 Primo closing a quota €30m per Claris Biotech I, fondo biotech promosso […] CLARIS VENTURES LANCIA UN FONDO DEDICATO AL BIOTECH ITALIANO
Aprile 7, 2020 La rivista Prisma dedica un articolo a Claris Ventures La rivista Prisma […] Claris Ventures sulla rivista Prisma di Aprile
Aprile 7, 2020 Covid-19: new report from Claris Ventures on development of drugs and vaccines […] COVID-19: Claris Ventures publishes its report on vaccines and drugs in development
Aprile 7, 2020 Business Insider: Claris, il primo fondo di venture capital italiano che investe […] Business Insider: Claris, il primo fondo di venture capital italiano che investe solo nel biotech tricolore
Febbraio 14, 2020 Ciro Spedaliere from Claris Ventures in the Life Science Panel of Aifi […] VentureUp Forum 2020
Novembre 16, 2019 Claris Ventures special guest at 39° Congresso Nazionale della Società Italiana di […] Claris Ventures special guest at 39° Congresso Nazionale della Società Italiana di Farmacologia (SIF)
Luglio 5, 2019 Kither Biotech raises a €5.6m financing round to support the clinical development […] Kither Biotech raises a €5.6m financing round to support the clinical development of a new drug for cystic fibrosis and other pulmonary diseases
Maggio 20, 2019 Claris Ventures guest speaker at “The drug from basic research to therapy” […] Claris Ventures guest speaker at “The drug from basic research to therapy” convention organized by the Italian Society of Pharmacology
Maggio 2, 2019 Pietro Puglisi of Claris Ventures, interviewed by national TV RAI Pietro Puglisi from Claris Ventures interviewed by national TV
